Abstract
Trilinolein, isolated from the traditional Chinese herb Sanchi (Panax notoginseng), has been shown to have myocardial protective effects via its antioxidant ability.
However, the cellular and molecular mechanisms of the protective effect of trilinolein
in the heart remain to be elucidated. Oxidative mechanisms have been implicated in
neonatal cardiomyocyte hypertrophy. We therefore have examined whether trilinolein
attenuates reactive oxygen species (ROS) production and thus ET-1-induced hypertrophy
of cardiomyocytes. Cultured neonatal rat cardiomyocytes were stimulated with ET-1
(10 nM), [3
H]leucine incorporation and the β-myosin heavy chain (β-MyHC) promoter activity were
examined. Trilinolein (1 and 10 μM) inhibited the ET-1-induced increase of [3
H]-leucine incorporation in a concentration-dependent manner. Trilinolein (1 and 10
μM) also inhibited ET-1-induced β-MyHC promoter activity in cardiomyocytes. We further
examined the effects of trilinolein on ET-1-induced intracellular ROS generation by
measuring a redox-sensitive fluorescent dye, 2′,7′-dichlorofluorescin diacetate, fluorescence
intensity. Trilinolein (1 and 10 μM) inhibited ET-1-increased intracellular ROS levels
in a concentration-dependent manner. This increase of ROS by ET-1 (10 nM) or H2O2 (25 μM) was significantly inhibited by trilinolein (10 μM) and N-acetylcysteine (10 mM). Moreover, ET-1- or H2O2-induced β-MyHC promoter activity and protein synthesis were also inhibited by trilinolein
(10 μM). These data indicate that trilinolein inhibits ET-1-induced β-MyHC promoter
activity, and subsequent hypertrophy via its antioxidant ability in cardiomyocytes.
Key words
Trilinolein - endothelin-1 - cardiomyocyte hypertrophy - reactive oxygen species
References
- 1
Levy D, Anderson K M, Savage D D, Balkus S A, Kannel W B, Castelli W P.
Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart
Study.
Am J Cardiol.
1987;
60
560-5
- 2
Morgan H E, Baker K M.
Cardiac hypertrophy. Mechanical, neural, and endocrine dependence.
Circulation.
1991;
83
13-25
- 3
Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H,
Aikawa R, Takano H, Yazaki Y.
Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy.
J Biol Chem.
1996;
271
3221-8
- 4
Force T, Haq S, Kilter H, Michael A.
Apoptosis signal-regulating kinase/nuclear factor-kappaB: a novel signaling pathway
regulates cardiomyocyte hypertrophy.
Circulation.
2002;
105
402-4
- 5
Choukroun G, Hajjar R, Kyriakis J M, Bonventre J V, Rosenzweig A, Force T.
Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.
J Clin Invest.
1998;
102
1311-20
- 6
van Wamel A J, Ruwhof C, van der Valk-Kokshoom L E, Schrier P I, van der Laarse A.
The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine
mediators of stretch-induced cardiomyocyte hypertrophy.
Mol Cell Biochem.
2001;
218
113-24
- 7
Yue T L, Gu J L, Wang C, Reith A D, Lee J C, Mirabile R C, Kreutz R, Wang Y, Maleeff B,
Parsons A A, Ohlstein E H.
Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists,
endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.
J Biol Chem.
2000;
275
37 895-901
- 8
Komuro I, Yazaki Y.
Control of cardiac gene expression by mechanical stress.
Annu Rev Physiol.
1993;
55
55-75
- 9
Cheng T H, Shih N L, Chen S Y, Wang D L, Chen J J.
Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes.
Cardiovasc Res.
1999;
41
654-62
- 10
Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T,
Matsumura Y, Ueno H, Tada M, Hori M.
Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled
receptor agonist-induced cardiomyocyte hypertrophy.
Circulation.
2002;
105
509-15
- 11
Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, Yamaguchi O, Matsumura Y, Ueno H,
Tada M, Hori M.
Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced
cardiomyocyte hypertrophy.
J Mol Cell Cardiol.
2002;
34
233-40
- 12
Luo J D, Xie F, Zhang W W, Ma X D, Guan J X, Chen X.
Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes.
Br J Pharmacol.
2001;
132
159-64
- 13
Shih N L, Cheng T H, Loh S H, Cheng P Y, Wang D L, Chen Y S, Liu S H, Liew C C, Chen J J.
Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene
expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat
cardiomyocytes.
Biochem Biophys Res Commun.
2001;
283
143-8
- 14
Hong C Y, Lai L J, Shiao M S, Chiang B N.
Effect of triacylglycerols on erythrocyte deformability in vitro
.
Prostaglandins Leukot Essent Fatty Acids.
1993;
48
351-3
- 15
Chan P, Thomas G N, Tomlinson B.
Protective effects of trilinolein extracted from Panax notoginseng against cardiovascular disease.
Acta Pharmacol Sin.
2002;
23
1157-62
- 16
Chan P, Niu C S, Cheng J T, Tsao C W, Tsai S K, Hong C Y.
Trilinolein preserves mitochondria ultrastructure in isolated rat heart subjected
to global ischemia through antioxidant activity as measured by chemiluminescence.
Pharmacology.
1996;
52
216-25
- 17
Chan P, Niu C S, Tomlinson B, Hong C T, Chen J P, Hong C Y, Tsai S K, Cheng J T.
Effect of trilinolein on superoxide dismutase activity and left ventricular pressure
in isolated rat hearts subjected to hypoxia and normoxic perfusion.
Pharmacology.
1997;
55
252-8
- 18
Wang D L, Chen J J, Shin N L, Kao Y C, Hsu K H, Huang W Y, Liew C C.
Endothelin stimulates cardiac alpha- and beta- myosin heavy chain gene expression.
Biochem Biophys Res Commun.
1992;
183
1260-5
- 19
Schluter K D, Piper H M.
Regulation of growth in the adult cardiomyocytes.
FASEB J.
1999;
13
17-22
- 20
Ito H.
Endothelins and cardiac hypertrophy.
Life Sci.
1997;
61
585-93
- 21
Chan P, Cheng J T, Tsao C W, Niu C S, Hong C Y.
The in vitro antioxidant activity of trilinolein and other lipid-related natural substances as
measured by enhanced chemiluminescence.
Life Sci.
1996;
59
2067-73
Prof. Paul Chan
Department of Medicine
Taipei Medical University
Wan Fang Hospital
No.111, Hsing-Lung Road, Sec. 3
Wan Shan District
Taipei City 116
Taiwan
Republic of China
Email: chanpaul@wanfang.gov.tw